The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
Marc-André d'EntremontChloë LaferrièreSimon BérubéÉtienne L CoutureSerge LepageThao HuynhLouis Verreault-JulienAnthony KarzonNoémie DesgagnésMichel NguyenPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
In this single-center retrospective cohort study, after adjusting for baseline covariates, early upstream ATTA with aspirin, ticagrelor, and UFH was associated with greater pre-PPCI TIMI flow and less definite acute stent thrombosis in STEMI patients, without increased bleeding risk.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- st elevation myocardial infarction
- antiplatelet therapy
- st segment elevation myocardial infarction
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- randomized controlled trial
- heart failure
- low dose
- liver failure
- prognostic factors
- cardiovascular events
- coronary artery disease
- cardiovascular disease
- patient reported